Statement Of Cash Flows [Abstract]

Zealand Pharma - Filing #1417063

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2018-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
0 DKK
1,018,149,000 DKK
0 DKK
0 DKK
0 DKK
1,018,149,000 DKK
846,729,000 DKK
0 DKK
846,729,000 DKK
0 DKK
0 DKK
0 DKK
0 DKK
571,541,000 DKK
571,541,000 DKK
0 DKK
0 DKK
0 DKK
Adjustments to reconcile profit (loss) [abstract]
Other adjustments for non-cash items
47,615,000 DKK
143,138,000 DKK
9,207,000 DKK
Interest paid, classified as operating activities
3,296,000 DKK
4,562,000 DKK
3,390,000 DKK
Interest received, classified as operating activities
0 DKK
895,000 DKK
5,413,000 DKK
Income taxes paid (refund), classified as operating activities
41,631,000 DKK
0 DKK
93,000 DKK
Cash flows from (used in) operating activities
1,211,971,000 DKK
688,716,000 DKK
409,455,000 DKK
Cash flows from (used in) investing activities [abstract]
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
0 DKK
167,791,000 DKK
0 DKK
Proceeds from sales of property, plant and equipment, classified as investing activities
0 DKK
0 DKK
25,000 DKK
Purchase of property, plant and equipment, classified as investing activities
22,133,000 DKK
25,044,000 DKK
21,036,000 DKK
Purchase of intangible assets, classified as investing activities
0 DKK
0 DKK
2,480,000 DKK
Dividends received, classified as investing activities
0 DKK
0 DKK
878,000 DKK
Cash flows from (used in) investing activities
18,121,000 DKK
196,807,000 DKK
51,666,000 DKK
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
748,975,000 DKK
791,503,000 DKK
645,145,000 DKK
Payments to acquire or redeem entity's shares
28,590,000 DKK
0 DKK
0 DKK
Proceeds from borrowings, classified as financing activities
647,906,000 DKK
0 DKK
0 DKK
Payments of lease liabilities, classified as financing activities
14,715,000 DKK
29,219,000 DKK
8,689,000 DKK
Cash flows from (used in) financing activities
1,332,751,000 DKK
760,941,000 DKK
674,480,000 DKK
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
102,659,000 DKK
124,582,000 DKK
213,359,000 DKK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
66,223,000 DKK
3,743,000 DKK
7,066,000 DKK
Cash and cash equivalents
1,129,103,000 DKK
960,221,000 DKK
1,081,060,000 DKK
860,635,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.